tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Brian Abrahams, 384 are a HOLD (37.14%), 647 are a BUY (62.57%), 3 are a SELL (0.29%).
Analyst Brian Abrahams, currently employed at RBC, carries an average stock price target met ratio of 49.33% that have a potential upside of 39.54% achieved within 226 days.
Brian Abrahams’s has documented 2,031 price targets and ratings displayed on 59 stocks. The coverage is on Healthcare, Industrials, Basic Materials, Technology sectors.
Most recent stock forecast was given on ACAD, ACADIA Pharmaceuticals.
Analyst best performing recommendations are on CDTX (CIDARA THERAPEUTICS).
The best stock recommendation documented was for PTCT (PTC THERAPEUTICS) at 6/18/2018. The price target of $38 was fulfilled within 1 day with a profit of $9.88 (20.63%) receiving and performance score of 206.35.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Mar-2026
$8
$0.65 (8.84%)
$12
2 months 1 days ago
(12-Aug-2026)
0/2 (0%)
$0.77 (10.65%)
Buy Since 18-Oct-2021
$7.5
$0.15 (2.04%)
$25
2 months 23 days ago
(20-Jul-2026)
0/16 (0%)
$0.31 (4.31%)
Buy Since 16-Jan-2026
$16
2 months 26 days ago
(17-Jul-2026)
0/2 (0%)
$12.43 (348.18%)
Buy Since 01-Sep-2021
$7.5
$0.15 (2.04%)
2 months 26 days ago
(17-Jul-2026)
0/3 (0%)
$0.28 (3.88%)
Buy Since 20-Jan-2026
$16
2 months 26 days ago
(17-Jul-2026)
0/4 (0%)
$11.91 (291.20%)
Which stock is Brian Abrahams most bullish on?
Which stock is Brian Abrahams most reserved on?
What Year was the first public recommendation made by Brian Abrahams?
